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HISTORY OF BLOOD TRANSFUSION 
The history blood transfusion is among the most 
fascinating, interesting, 1.1nusual and romantic part ot 
medical history. There is probably no other therapeudio 
measure in the whole range of medical soienoe whioh has 
waxed and wanned with such extremes in medical usage. 
The idea that blood contained the vital essence of life 
is almost as old as medicine itself. There is ab~ndant 
evidence in the ancient belief in the t.lse of blood as a 
remedy, the idea being that healthy blood should be used 
as a potion tor the treatment of various ills (70). And 
likewise the degrading etteots ot the abuse of blood in 
oases of perversion (20}. 
Historical beliefs regarding the efteots of blood: 
Pliny about 50 A.D. tells of the drinking of the 
blood of dying gladiators in the arena "'as if ot.lt ot 
living oups,"' tor epilepsy; that "'a man's own blood 
rubbed upon himself will relieve pain;"' and that the 
Egyption kings used baths of blood for the oure ot 
elephantiasis. Galen about 200 A.D. advised the drink-
ing of blood for the oure of various diseases, particu-
larly epilepsy (20, 70). 
One who drinks menstrual blood or the blood of a 
leper Will act as a lunatio, will be sexually uncontrol-
able and generally evil. The antidote is to eat surpents 
whose heads and tails h:ive been removed in the proper 
·"' 
manner. There were numerous, many not without humor, 
of the uses ot oata, doves, turtles and other animals' 
blood in various mixtures for treatment, especially or 
epilepsy. one girl, an epileptic, is mentioned, who 
atter taking oat's blood acted like a oat. It a blaok 
oat's tail be out off at the distal third, and the first 
three drops of blood given to an epileptic, it will act 
towards a oure; the blood from a wild oat should be even 
better. The blood trom the ear of a blaok oat should 
be of value in the treatment of erysipelas. The drink-
ing of blood of a weasel or of a dog for the bite ot a 
rabid animal was well recommended. The mixed blood of 
turtles, seals and man was used for the treatment ot 
epilepsy, fits and scurvy among the Norwegians, and that 
of the reindeer in Lapland. Mixed blood trom kids, geese 
and ducks was used tor diseases affecting the spirits. 
The flowing blood from the wounded soldiers was saved and 
drunk as a remedy. People would rush into the arena and 
drink the fresh flowing blood of the wounded and dying 
gladiators. Distillates from the blood were employed 
with other distillates of even ver:y obnoxious substances 
as the human bowel excreta for the remedy of many diaeasea. 
The blood was thought to contain various spirits and so 
it was used to treat oases that were thought to be due to 
the maladjustment ot these mythical tactors in the hope 
that it would restore the derangement (20). 
Veneseotion onoe a very oommon practioe: 
This historical comment would be incomplete and 
would leave a f'alse impression if blood letting was 
not mentioned. Bleeding has a prehistoric origin and 
may have arisen from the relief afforded by menstru-
ation,. nose bleed, and bleeding from piles ( 135). 'rbe 
rational was that bleeding with the copious forcing ot 
water washed and cleansed the blood (45, 57). Hippoorates 
460 B.C. advised it for hypochondria, gas dyspnea, pain 
in the ohest, flushing of' the face, apoplexy, epilepsy, 
and ~diseases oonneoted with collection of the humors", 
palpitation, livid sputa, quinsy, ·raver, and over filling 
of' the sto~aoh. Celsus about 25 A.D. recognized that a 
patients strength sho,1ld be oonsi dered; and that a patient 
with a high f'ever should not be bled. Galen about 200 
A.D. recommended quantitative blood letting, from 200 to 
500 oo in the. average oase. He i nareased the number or 
diseases tor which blood letting was used. It was pro-
bably upon his authority that ~t was extended later to 
almost every ailment (45). Bleeding beoame the fashion, 
oarried on withe.it reason onoe a year. Not only by the 
medioal profession, b1.1t by the barbers and the tenders 
of public bath houses. Excessive blood letting glasses 
were handed down from family to family as treasured heir-
looms. Some of the physicians bled their patients moder-
. 
ately, others bled them severely and repeatedly; and then 
because the patient :felt taint and weak and his p11lse 
was rapid and weak, he was still bled again (45, 57). 
The :t'aot is the first hum.an trans:t'usion was performed 
on a boy who was exhausted from repeated veneaeotion 
(158). A verse exaggerating the tendency to bleed with 
other procedures: 
"When patients to me apply, 
.I purges, bleeds, and aweats •em: 
It a:t'ter that they choose to die, 
1Jhat•s that to me? I let's em." 
.. 
Our own General George Washingt~n died from loss ot 
blood at his physicians' hands (45)• 
Tranatllsion without authentic support: 
The old Egyptian writings reter to blood trans-
fusion as a prooed~re to be used as a means ot medi-
oa tion tor the kings and pr1Dces (54). Herophilus; 
the great Alexandrian anatomist speaks o:t' blood trana-
:t'usion. It was condemned by Pliny and Celsus (42). A 
jewish physician in 1492 took blood from three boys tor 
Pope Innocent VIII. There is some doubt as to whether 
the transfusion was done. It is thought that a drought 
was made for the Ponti:t't but he and the boys all died 
(34, 57}. Cardemes in 1556 ottered to redeem the un-
regenerate by transfusion of blood from the virtuous. 
Andreas Libavius describes a blood tro.nstusion before 
Harvey's discovery ot the oiro~lation ot the blood which 
was 1613 to 1616 (20, '10}. In his description ot the 
prooedu.re, he tells how the blood :rrom a strong healthy 
rob1.1st young man may be transferred with two silver 
tu.bes to the vessels of a thin, emaoiated, weakened old 
man hardly able to oontain his own soul, giving him 
life and strength. Then he cautions that the yo1.1ng man 
be given good oare and food so that he will not su.tfer. 
But writers refer to this reterenoe as ironical and doubt 
it Libavi.is ever saw or ever did a transfusion (20, 70). 
The first blood transtusion has been aooredited to 
Franoesoo Foil!, a Florentine physician, in 1654• He used 
a silver tube in the artery of the donor and a oann1.1la 
in the vein of the recipient, oonneoted by a hollow pipe 
made from a blood vessel from an animal. About the same 
time, a monk of Cluny demonstrated the possibility of 
intravenous trans:rusion using two silver tubes connected 
by a leather ball and oontaining valves so that the 
·quantity of blood oould be measured (20, 70). But these 
do not have authenticated reoords (57). 
The first authentio blood tranfusions: 
The first a1.1thentioated blood transf~sion was per-
formed in England by Riohard Lower trom dog to dog. In 
1665 he gave a demonstration of the procedu.re before the 
Royal Sooiety in London, uniting an artery of one dog 
to a vein or another by means of two q1.1ills or silver 
tabes (20, 70, 158). 
jean Baptiste Denys or Denis of Montpelliar, 
physician to King Louis XIV, is given the honor ot the 
first transfusion to man (20, 70, 158). In 1667, he 
· injected the blood of a oalf or lamb into the veins 
of a youth, somnolent and listless from loss ot blood 
by repeated veneseotion. The patient became greatly 
improved and recovered. About this time, he transfused 
a well man with 20 ounces or blood from a lamb after 
having bled him ot 10 ounces. The man suttered no bad 
results. Denys performed the procedure a third time; 
this time on a moribund patient who died a few hours 
later. His fourth transtusion was performed on an in-
sane person and repeated twice. Following the seoond 
transfusion "his arm became hot, the pulse rose, sweat 
burst out over his forehead, he complained ot pain in 
his kidneys and was siok to his stomach. The next day, 
the urine was very dark, in tact black.~ Following the 
third transtusion which was given at his wite's request, 
he died. Denys was tried tor murder but exonerated. 
But was with.strained from further transfusions on h11D1ans 
e:xoept by the approval of the taoulty ot medioine ot 
Paris, who were in opposition to blood transfusion. (158) 
Lower in November 1667 transfused a siok man, Cogo, 
from a sheep; he died probably from oomplete hemolysia 
(20, 70). Aooording to ~immerman & Howell, the trans-
rusion performed by Lower in November 1667 was suooess-
f'ul and was also repeated successf'ully on the same 
patient (158). Due to the tatalies following blood 
transtusion, public opinion became against the procedure 
and as a resiJ.lt the law of France and England prohibited 
it on hwnans; and the Pope in 1678 gave an ediot pro-
hibiting it. So the practice tell into oblivion tor 
about the next century and a hal:f (20• 70, 158). Germany 
and Italy both had their experimenters, but the procedure 
likewise was discontinued in both places (158). 
About 150 years later, interest was agdin aroused 
in blood transtusion. In 1792 at Eye in Sultolk a Dr. 
Russell transfused the blood or two lambs into a boy 
suffering trom hydrophobia and tne recovery of' the boy 
was attributed to the transfusion. In 1796 Erasmi1s 
Darwin advised transfusion tor "piJ.trid f'ever", oanoer 
ot the esophagus and oases ot malnutrition. He suggested 
the use ot goose quills oonneoted by a short ohioken•a 
gut. There is no record that he followed his own advice 
(70) • 
.Tames Blundell, an Englishman, in 1818 published 
his suocesstul experiments on transfusion following 
hemorrhage by the use or syringe with a three way stop-
cock; and of air injection in dogs - it required five 
drams of air in a very small dog to even cause any etteot 
(14). He was the first to transt~se blood from human to 
htuaan and to show the value or this prooedu.re in 
hemorrhage (158). In 1820, he stated n•that trans-
fusion by syringe is a :feasible and useful operation, 
and that after undergoing the usual ordeal of negleot, 
opposition and ridicule, (t will hereafter be admitted 
into general praotice.n' {70) The great diffioulty in 
the use of the operation was the ooagulation of the 
blood. Bisohoff in 1835 tried to overoome this by the 
use or defibrinated blood as did others {70). 
Martin or Berlin 1859 p~blished records or 57 
transfusions, 43 of which were successful. The fatali-
ties were thought to be due to air embolism,. btlt were 
more likely the result of incompatibility. Ma11y and 
varied apparatuses were devis•d. Higginson 1857 added 
the rubber syringe with ball valves {70}. Braxton 
Riots in 1868 attempted to prevent blood ooagulation 
with sodium. phosphate (158). A SUDllllary made by the 
obstetrical society ot London 1873-74 showed the re-
sults on the whole discouraging. Blood transfusion 
was used when the patient was "in extremisn and animal 
transfusion whioh was still used hampered asepsis. 
Karst and Highmore 1874 proposed the subcutaneous in-
jection ot defibrinated blood (70 & 158). 
Discovery of the blood groups: 
Landois observed agglutination and hemolysis 1875 
and explained hemogl-ol>lhuria on that basis following 
blood transfusion (57). 
Probably the most outstanding work contributed 
toward blood transfusion was the work of Landsteiner in 
1900 9 and ot Shattook independently, demonstrating the 
presence ot !so-agglutinins and iso-agglutinable sub-
stances in the human red blood corpuscles. The next 
great step was made by jansky in 1907. He showed that 
all human blood talls into tour groups. Hektoen in 1907 
pointed o~t the danger of !so-agglutination in the 
transfusion of blood. Moss 1910 confirmed jansky's work 
and added that iso-hemolysis ot red.cells follows pre-
viot1s agglutination, but that agglutination may ooour 
without hemolysis (70, 158). Ottenberg in 1908 developed 
clinioal tests tor blood typing and applied olinioal tests. 
to human blood transfusion (158}. 
The development ot teohnio: 
The injection of normal saline solution in 1875 to 
1880 almost oompletely replaced blood transfusion. Blood 
vessel surgery was improved; ~nd petrolatum and paraffin 
coated vessels and syringes to prevent coagulation de-
creasing the danger of blood transfusion about 1900 (158). 
Curtis and David in 1911 used parattin coated Y-tube 
and syringe. Two years later KimptQn and Brown intro-
duced the Kimpton-Brown paraffin coated tube. The same 
year, 1913, Lindeman revived the multiple syringe method 
ot Ziemessen 1892. The Blundell method ot 1818 was 
revived. Unger in 1915 devised a four-way valve syringe 
attachment~ in which the outlets to the donor and reci-
pient were alternately oonneoted with the syringe and 
with a reservoir of saline or citrate solution. Many 
modifications have been made of these instr·i.1.tD.ents, 
notably are those or Bernheim, janes and Soanell (?O, 158). 
The use ot antiooagulat•nta: 
The blood clotting in the instr11ments still caused 
trouble. Detibrinated blood had been tried and abandoned. 
Braxton Hicks 1868 had tried unsuooessfully to use sodium 
phosphate to prevent coagulation; Landois in 1892 recom-
mended the use of hirudin, but the narrow range between 
the toxic and the effective dose prevented the adoption 
ot it. Hustin ot Belgium in 1913 introduced the use ot 
sodium citrate as an anticoagulant. The first trans-
fusion with it was done byAgote or Buenos Aires November, 
1914. Lewisolin improved the sodium. citrate teohnio ot 
blood tranatusion. The knowledge of blood transfusion 
became universal following its introd~otion and use in 
the great wars in 1917 by Ameriaa• (20, 70, 158) 
THE FOUR BLOOD GROUPS AND ISO-AGGllJTINATION 
The normal human red blood oells form an even 
suspension when mixed with normal saline. Mixing the 
serum or the same individual or that of a person of 
the same blood group has no reaction on the suspension, 
but if seru.m ot an inoompatible blood is mixed with this 
suspension clumping of the cells or agglutination re-
sults. Upon this phenomenon is based the division ot 
humans into tour main blood groups and into a tew aub-
groupa. This agglutination is a speoitic reaction and 
depends upon two substances, one in the red blood oells, 
called agglutinogen; and one in the serum, called 
agglutinin. This reaction is or the same order as the 
Widal and other specific agglutination reactions (ltH). 
Landsteiner (151) has described two agglutinogena 
A and B; and two agglutinins Alpha (or anti-A) dnd Beta 
(or anti-B). Several nomenclatures of the Landsteiner 
blood groups showing the respective agglutinogen and 
agglutinin are given in table I. The International 
Nomenclature was otticiall7 recognized by the Health 
Community or the League of Nations. The Moss and Jansky 
numberings are aonfusing. The International Nomen-
clature corresponds to the agglu. tinogen content in the 
red blood cells. It is possible for an individual's 
TABLE I ( 151) 
Classification & oo.m.position ot the Ladsteiner 
blood groups: 
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serum to lose or ohange its speoifio iso•agglutin1na 
but cell receptors or iso-agglutinogens are constant, 
and sinoe the blood groups are named by the type ot 
iao-agglutinogen present in the oells, the blood groups 
do not ohange. They are inherited and last through 
lite. The blood group speoitioity if not present at 
birth, whioh it usually is, appears within three months 
(54, 115). During embryonic development and the first 
three months of life, the human being does not possess 
speoif'io aggl·11tination power in the blood (40). The 
results of the sera of eaoh group mixed with the red 
blood oells of eaoh other group is shown in Table II 
and as can be seen, from the table, the blood group of 
any individual may be determined by testing his red 
blood cells with the sera of A and B grou.ps. Group O 
red blood oells will not agglutinate with either serum. 
The cells of group A B agglutinate with eaoh serum. 
Groi.lp A oells will aggli.ltinate with B serum and group 
B oells will agglutinate with A serum. 
TABLE II (151} 
Serum ot • Aggluti- • Aggluti-. Red Blood oells ot 
Group • no gen . nin in • group 
• in oella • serum • 0 • A • B • AB 
• • Alpha & • • • • 
0 • • Beta • • II • # • i 4 • A • Beta • • - =II • ~ • B • Alpha • • II • • 
A.B • A&B • • • ~ • ... •· -
II signifies agglutination 
~ signifies absenoe ot agglutination 
Should there be any oase of doubt following the 
reaction of unknown oells with known serum, the unknown 
serum may be tested with a known oell group suspension. 
Only those agglutinins are present in the serum tor 
which there are no aggl~tinogens in the red blood cells. 
Aa: Red oells of group A have agglutinogen A in them, 
their serum has anti-B or Beta agglutinin in it; red 
oells of group B have agglutinogen B in them, their 
serum anti-A or Alpha agglutinin in it; red cells ot 
i 
group A B have in them agglutinogen A and B, their serum 
has no agglutinin in it; red oells of group O have no 
aggliltinogen in them, their serum has both Alpha and 
Beta or anti-A and Anti-B agglutinins in it. Because 
group A B has no agglutinin in its serum and cannot 
agglutinate any red blood cells, it has been called the 
universal recipient. Group o because there are no 
agglutinogens in its red blood cells and they cannot 
be agglutinated by any serum has been called the uni-
versal donor (54, 56, 151). Some men advise using 
universal donors tor transfusions always and of giving 
any tYPe ot blood to universal recipients (113, 114) 
but this is dangerous without satisfactory eross-
matohing, for it otten eauses reactions (54, 106, 108). 
It should only be used when it is impossible to get the 
proper type of blood 
The Teehnio of Blood Grouping: 
In. blood grouping we must oonsider the sera, the 
red blood oell suspension, and the various grouping 
tests. Only sera ot A and B groups are neoessary as 
already explained. Sera of high titer should be used 
to prevent errors, as blood oells very in their sens1-· 
tivity. Serum trom certain pathological conditioned 
patients may show pseudoagglutination and autoaggluti-
nation whiah may ~e mistaken for isoagglutination. 
The: sera ot very young and very old individuals usually 
shows low agglutinin titer - therefore, sera or healthy 
middle aged individuals should be used for testing sera. 
The blood is collected in small test-tubes, allowed to 
olot, the olot is rimmed with a stirring rod, and the 
serum is separated by aentrifuging or standing in the 
1oe box over night. The serum is transferred by pipettes 
to small sterile vials oapaoity ot about two oo eaoh. 
Sterile teohnio is used throughoilt the entire pro-
oedure. The serum is stored in an ioe box; preserva-
tives are unneoessary, but phenol one part of five 
per oent in normal saline to nine parts of serum has 
been used (151). Different oolored preservatives· 
(118) have been reoommended and used to differentiate 
the sera by oolor. To A serum per co is added 0.01 ao 
eaoh or one per oent aqueous solution or neutral 
aoritlavine and 0.5 per oent aqueous solution of basio 
fuohsin. To B serum per oo is added 0.01 oo ot per 
oent aqueous solution or brilliant green. Commeroial 
sera has been round not always reliable (120). 
The red blood oell suspension should be fresh. 
Blood maybe gotten by stilet punotilre or the lobe or 
the ear or end of a finger as for a blood oount. Two 
drops or the blood are suspended in 5 oo ot normal 
saline (151) or in 5 oo of one per oent sodium oitrate 
in normal saline solution ( 54). The s'-lspension sh91.1ld 
be washed if there is the tendenoy or pseudoaggluti-
nation or rouleaux formation (54 & 56). This is done 
by oentrituging, pouring otf the supernatant fluid 
and resuspending in normal saline making a two to five 
per oent suspension. It the serum is to be tested 
also, venepunotllre is preferable, using a tew drops 
for the red oell suspension and the serum prepared aa 
already desoribed. Kno~n oell suspension may be pre-
served (see blood preservation) then washed and 
resuspended when needed for testing unknown sera (151). 
The blood grouping tests may be done macrosopi-
cally or microscopically. LandstP.iner's macroscopic 
or microscopic technic (151): A drop of ea.ch of the 
unknown cell suspension, of saline, and. of testing 
serum are mixed in a small test tube, inside diameter 
7 mm. Upon standing, the reaction can be seen with 
the naked eye after a few minutes but should stand 
an hour. If desired a drop of the mixture may be 
transferred to a slide with a stirring rod and looked 
at with a microscope low power. A control should be 
run with this procedure. The reaction can be 
facilitated by centrifuging at 2000 revalutions per 
minute for three minutes. The tubes are then shaken 
until the control is evenly suspended and then read 
with the naked eye. The usual method used (151): 
One drop of A serum isput on the left end of a slide 
and one drop of B serum put on the right end of the 
slide, and one drop of the unknown cell suspension 
is mixed with each. The slide is tilted back and 
forth for 5 to 10 minutes, then the drops are 
covered with cover clips to facilitate microscopic 
examination. Examination is completed after an hour. 
Pseudo agglutination is possible in this last test (151). 
Young ( 155) states that typing a.nd cross matching 
by covering the ~erum and red blood cell suspensions 
with a cover glass is very dangerous, for that pre~ 
vents agglutination or hemolysis. And he cites 
cases in his own experience to prove this. The 
hanging drop method. observed for 45 minutes to an 
hour makes the procedure safe when done at 37 degrees 
centigrade or room temperature (54, 56, 155). 
SOURCES OF ERROR IN PI,OOD GR01TFING 
False negative reactions: 
Weak sera or sera of low titer and old sera 
may not have any affect upon the red blood suspen-
sions. Therefore, it is well to use controls. If 
the mixture of cell suspension and serum are not 
observed for a long enough period of time a positive 
reaction may be missed. Very concentrated red blood 
cells delny snd weaken the reaction. This may be 
avoid.ed by making a two to five per cent suspension 
of the red blood celJs. The agglutinogen in some 
red blood cells is very insensitive and may be the 
source of error. Such a patient of A B group was 
transfused 18 times with B blood before the error 
w.as detected. Hemolysis some times appears with 
fresh serum and masks agglutination, for the blood 
cells are hemolyzed as fast as• they are agglutinated; 
but the scarcity of cells in the suspension should 
indicate hemolysis. The solution will also have a 
tendency to take on a pin}; color, but this is hard 
to detect in poor or artificial light. Hernolysis 
has the same significance as agglutination and never 
takes place without agglutination. Serum that has 
been kept in the ice ~ox over night will not show 
this sudden hemolysis action (106, 108, 151). 
False positive reactions: 
Pseudoagglutination is the rapid settling 
out of red ~lood cells in acute infections. The 
cells settle out in piles like coins known as 
roule~ux-formation. When the rouleaux are very 
marked, the cJumps become more irregular and 
simulate true agglutination; but the rouleaux are 
always present and result from the action of the 
acutely infected person's serum upon its own cells 
as well as the action of that same serum upon any 
red blood cell suspension. This phenomenon is used 
in clinical medicine in the sedimentation rate tests 
(32). Other factors whlch favor its occurrence are 
high concentration of serum and high temperature. 
It very rarely occurs in Landsteiners test-tube test. 
On the slide, it can be distinguished from iso-
agglutination by a drop of saline or ,,.,y pressing down 
on the cover slip over the preparation, either of 
which breaks up the clumps in false agglutination 
but will not affect true agglutination (29, 54, 106, 
108, 151, 158). 
Autoagg1utination: 
Cold or autoaggluti~~tion takes place with many 
sera mixed with red blood cells at low temperatures, 
as zero to five degrees centigrade. They are specific 
or non-specific (81). In some pathological conditions 
autoagglutination takes place even at room temper-
ature. This can be overcome by making a two to five 
per cent suspension of the cells in normal saline. 
Among the conditions causing it are: Paroxysmal 
hemoglobinuria, syphilis, sybilitic or hypertrohic 
cirrhosis of the liver, hemolytic icterns, pneumonia, 
Raymonds disea.se, tryanosamiasj_s, and severe an~mias 
and cachexia. Autoagglutination is in some cases 
inherited (29, 30, 54, 106, 108, 140, 151). 
Panagglutination: 
Some saline red blood cells suspensions after 
having been kept a long time will be agglutinated by 
any serum, even their own, and by the serum of A B 
which has no agglutinins in it. Friedenreich says 
this is due to bacterial contamination (15, 29). 
Panagglutination may also occur in bacteremia and in 
chronic suppurations (29). 
Anomalous agglutinins: 
Anomalous agglutinins were found in about three 
per cent of sera according to Lansteiner and Levine 
(P2). These rarely a.ct at room temperature and the 
red blood cells o:f such sera show normal grouping 
reactions. These may be specific cold agglutinins 
(106, 108, 151). 
Various tissue extracts cause f'alse agglutinins 
as Wharton's jelly fr.om the umbilical cord (106). 
REACTIONS FOLLOWING TRANSFUSION 
Reactions following blood transtusion vary 
with the different olinios and the difterent oper-
ators all the way trom one halt ot one per oent to 
twenty per oent, if reports oan be depended upon 
(84, 86, 104). Aooording to Lewisohn {84, 86} 
the reactions in pne hospital when done by him were 
only one halt ot one per oent, b~t when left to 
the hospital start ranged trom 10 to 20 per oent. 
The operator and his teohnio must be an important 
tao tor. 
Incompatibility reactions: 
Inoompatibility between the donors and the 
recipients blood may be due to the one of the follow-
ing causes: {a} Errors in gro~ping whioh is itself 
d~e to the following in order ot greatest frequency: 
Poor teohnio tor •htch there is no justitioation; 
the use of low titer or contaminated test sera; weak 
agglutinins or agglutinogens in the reoipients blood; 
pseudoagglutination, cold agglutination and the sub-
groups; contamination ot reoipients blood by bacteria, 
anomalous or atypioal agglutination (29, 106, 108). 
(See ohapter on errors of blood grouping) (b) In-
discriminate use of the universal is dangerous because 
incompatibilities do ooour from the use of such (41, 
106, 108). {o) Immune 1soanti-bodies and hemoly-
sins may oause incompatibility (106, 108}. For a 
discussion ot symptoms, treatment and results ot 
incompatibility see the chapter on transfusion 
nephretidea. (d) Incompatibility of white oella 
have been found by experimentation. Suoh inoom-
pa ti bili ty tho11gh not common do give reactions. 
( 84 ' 86 ' 104) • 
Citrate Reaction: 
Mild reactions whioh oocur so commonly follow• 
ing transfusion with some operators and so rarely 
with other operators have been blamed on the toxicity 
ot the sodium citrate solution used by the advocated 
of unmodified blood:, and upon the incipient coag11-
lative changes in the transf11sed blood by the citrate 
advocates. But Lewisohn (84, 86) blames them to 
improperly prepared citrate, to unclean apparatus, 
and to poor teohnio. His citrate solution must be 
prepared with triple distilled water and made up with 
normal sodium chloride. Refer to separate discussion. 
These reactions are oharaoterized by mild rigors with 
transitory rise in temperature following a mild ohill, 
and are as often present when citrate is not used 
(16, 67). Some olaim that citrate reactions are not 
harmful but benefioial. It would be better to use 
other methods or chill and fever, whioh can be oon-
trolled and controlled independantly of the 
transfusion (10, 138). 
Allergio Phemomena: 
rf there is a history of allergy in the 
recipient, a tast donor should be used and if a 
reaotion still ooours it ean be relieved with adren-
aline and morphine (163, lOla). Allerg1o donors 
should not be used (29, 112). It the reo1pient has 
had former transfusion or serum administration, 
there is danger of an anaphylaotio reaotion. The 
greatest danger of this is between three to six 
weeks after the administration of blood or serum. 
Therefore, upon repeated transfusion even from the 
same donor, the blood of the recipient and donor 
should be oross-matohed (16, 29, 106, 108}. The 
allergic symptoms may take the torm of urtioaria, 
asthma, localized edema, or severe shook. Edema 
and urt1oaria are dangerous if they hit the glot1s. 
It suoh ooours, intubation or traoheotomy may be-
oome neoessary. Epinephrine is used in the allergio 
reactions. (16, l-25f One death from anaphylaxis 
has been reported {25). 
Systemics or constitutional reaotions: 
Reactions seen after the transfusion of certain 
pathological conditions in which there is a very 
active hemolytia agent at work. The latter may appear 
r 
in purpura, hemolyti~ jaundioe, leuoemia and sepsis. 
Reaotions or this type can neither be foreseen nor 
a.voided, but the possibility of their ocourr'ance 
should be kept in mind so that prompt measures may be 
instituted to counteract them if they should oocur 
(16, 84, 104, 116) 
Heart failure and pulmonary edema may result 
trom the transfusion, depending, of course. upon 
the condition ot the patients oiroulatory apparatus. 
It is made more possible in a patient with a weakened 
heart oondition due to a long standing anemia, pre-
vious failing heart to whatever oause, valvular 
disease, and arterial sclerosis and hypertension 
(12, 105). Rapid administration inoreases the danger 
or aoute cardiac dili ta ti on, especially when the 
myooardiwn is all ready weakened. a.rile pointed out 
that the hearts work increases in geometric ration 
to the volume of' blood. (147) It oan be prevented 
by giving the blood slowly. If' it ooours venesection 
must be performed at onoe (12). The amo~nt of blood 
administered sho..ild not exceed· 1/6 to 1/5 of the 
oaloulated circulating blood of the recipient because 
of the danger of overloading the circulatory system 
(29). 
"Multiple emboli appear occasionally, usually 
in patients with endocarditis, or a blood stream 
infeotion" (105). A thrombooyte orisis oan be 
ind~oed in oases of thrombooytopenia purpura by 
blood transfusion {142). nRetinal hemorrhage pro-
bably oco~s more frequently than is thought" (105). 
Transtusional fatalities are more frequent in diseases 
of' the blood and during sepsis than in acute hemorr-
hage (29). 
Transmission ot disease: 
The transmission ot disease from the donor to the 
recipient is a real danger and must always be g·11arded 
against. The reoipient may also be endangered by blood 
from a person whose hemopoetic apparatus is not funct-
ioning properly (29). (Refer to separate disoussion) 
Embolism and thrombosis: 
The danger or embolism and thrombosis is small, 
especially if' faultless technio is used (29); except 
in endooarditia and blood stream inf'eotions (125}. 
Air embolism, the greatest f'ear of distorioal trans-
fusion and accepted oause of' many deaths is of no 
danger with proper teohnio, "The amount of air whioh 
may be aooidentally injeoted into h~ans during an 
ordinary intravenous injeotion should oocasion no 
olinioal manif'estatioIB" (146}. 
The ~se of olean apparatus: 
Any debre in the transtusion apparatus, whether 
trom former transfusion or tubing, even though minute 
causing reaotions, some times alarming reaotions 
(84, 86, 106, 108). Therefore, transfusing appara-
tus must be metioulously olean. It is easier to 
clean right after using. It is washed with running 
water several times after the water running through 
it is olear. After it is clean it is dried with 
compressed air, wrapped in towels and sterilized 
thoroughly. It there should be may partioles ot 
blood remaining in it, they will probably cause a 
reaotion in the next recipient. New r1.1.bber tubing 
causes serious reaotions from the sultur oompounds 
and powder washed from the tubing. The tubing is 
soaked tor several hours and then boiled in five 
per cent sodium. hydroxide solution for ten minutes. 
It is then treated in the same manner in a two per 
oent hydroohlorio acid solution and washed over 
night in running water and sterilized tor 30 minutes 
at 20 poands pressure in the autoclave (log, 111}. 
Lewisohn's teohnic (85) is much more thorough~_·it 
follows: 
The apparatus is thoroughly washed with cold 
water after each transfusion, then with dilute sol-
ution ot green soap to whioh has been added oo.mpound 
solution of oresol to make about l;~ solution, and 
then thoroughly rinsed in tap water. All parts are 
then put in a large pan containing sodium hyderoxide 
in 0.1% solution and boiled five minutes and then 
rinsed in distilled water to remove the hyderoxide, 
rewashed with triple distilled water for the glass 
ware and the rubber tubing, then assembled and 
sterilized in metal boxes or speoial bundles in the 
autoolave. 
The glassware and rubber tubing are boiled 
separately. The needles are sharpened before being 
treated and are_boiled for 3 minutes in 0.1% solution 
ot sodium hydroxide. The reoipient and donor bundles 
are done up and labelled separately for autoolaving, 
oontaining: Donor: Two pyrex oylinders 500 and 10 oo, 
respeotively, one glass rod, two towrniquets, two 
needles gauge 13 and 15, Leur adopter and rubber tub-
ing, one ampule or 30% so_ditun oi trate. Reoiptent: 
A metal box containing glassware, rubber tubing and 
oannulaa (85). 
Coagulative and temperature ohanges in the blood: 
It has been demonstrated that blood is toxic 
in direot proportion to the ohemioal alterations 
toward ooagulation. This is particularly dangerous 
because the change invisible undetectable in the 
preolot state (54, 106, 108). 
Warmed blood that is heated above body temperature 
whether given while above body temperature or not, 
hemolyzes due to the efteot of the heat upon the 
erythrooytes. The symptoms, treatment and e:f'teot 
are the same as :f'or imoompatibility (12, 105). 
Blood may be chilled or even kept in the ioe 
box without deleterious e:f:f'eots if' it is warmed to 
body temperature when given. But if' it is given 
oold, it is said to oause a reaotion. This may 
account for some of' the reactions that have been 
blamed on to oitrate (10). However, Lewisohn (85, 86) 
maintains that injeoted cold blood does not give any 
reaotion. But it does sound reasonable that oold 
blood might give a chill. 
Death :f'rom blood transfusion: 
Death :from blood transfusion is mainly due to 
elimination o:f :foreign substanoes overtaxing certain 
organs as the kidneys, liver and heart oausing in-
su:f':f'ioienoy of' those organs, as in the pest renal 
nephritides :f'rom incompatibility. Fatalities are 
more :frequent in t:raas:fusion in diseases or the blood 
and in sepsis than in aoute hemorrhage (29). The 
death rate :f'rom. blood transfusion was figured by 
Tiber (141) in 1930 to be 0.39 per 1000. A muoh 
greater ratio than this of' transfused persons die, but 
it is figured that they die of the disease :for whioh 
they were transfused. 
IOST TRAIYSFTTSION NEIRRITIDES 
The post transfusion nephritides are, due 
to their clinical aspect, physiopathological 
characteristics, modes of appearance, related to 
the acute chemical nephritides. The treatment is 
not satisfactory but prophylaxis is. The prophy-
laxis is ensuring compatibility of blood before 
the transfusion; not warming the nood above body 
temperature; and stopping the transfusion with the 
first signs of distress. The prognosis is guarded 
to favorable with exceptions (16, 116, 143). 
The ~our clinical phases: 
Clinically, there are four phases of the trans-
fusion nephritis: 
First: The alarm period with precocious sub-
jective symptoms, and the transfusion is discon-
tinued with a minimum of 20 to 30 cc of blood having 
been· injected. Therefore, there may oe normal com~ 
plication. The symptoms are: tingling pains 
shooting over the body, a fullness in the head to a 
headache, cardiac consciousness with a feeling of 
tightness and constriction over the precardiurn and 
chest; an excruciating throbbing pain in the lumbar 
region; slowly the face becomes prematurely colored 
a dark red to a cyanotic line; respiration be-
comes somewhat labored and the pulse rate slow, 
dropping suddenly to 20 or 30 beats a minute; 
vomiting, more or less violent rigor; uncons-
ciousness may be P!P-sent for a few minutes; urti-
carial erruptions arpear in ahout half the cases; 
sudden palor followed ~y cyanosis; the pulse be-
comes very rapid, weak and thready; the skin ~e­
cornes cold and clammy; in fifter~ minutes to an hour 
a chill occurs followed by a hi~h fever, te~perature 
ranging from 102 to 106 degrees; the patient may 
become delirious (5, 16, 104, 121, 143, 147). The 
~atient may rarely die immediately (113, 115, 147) • 
.A. reaction described. by DeGowin is interesting, 
"When 125 cc of "blood. had been given, the :patient 
complained of a feelircg of constriction in the chest 
and severe shortness of breath. The administration 
of bJ.ood was promptly discontinued. She became in-
tensely cyonotic and dyspneic. A marked chill occurred 
and the oral temperature rapidly rose to 106.2 degrees 
F. The pulse rate was 140 and the respiration rq,te 
44 1er minute." The next day tbe patient was feeling 
netter. 
Tbe delayed reaction: 
However, these symptoms may not arrear until 200 
to 300 oo or blood have been given, or they may not 
appear until the transtusion has been oompleted and 
thus be oompletely skipped. The following pre-
oautions should always be taken to proteot the patient 
against re~otions and to show the dootor the reaction 
before too mu.oh blood has been administered if there 
is going to be a reaction. 1. No morphine should 
be given before the blood transfusion, for this would 
mash the cardiao consciousness, lumbar pain and head 
ache. 2. Every precaution for proved compatibility 
should be taken. 3. 'l'he ~lood should not be heated 
above body temperat..ire. 4. The transfusion should 
be begun slowly. 5. Every sign of discomfort on the 
part of the patient should be minded and watched. 
However, there may be seemingly reactions that are 
psyohio, or oomatose and sleeping patients may not 
show reaction (16, 143}. 
Second: Anuria and ol1gur1a start about and 
between six to twenty-tour hours after the transfusion 
with or without a phase of alarm. The condition and 
the taking of a urine speoiment is suggested by hema-
turia or because no ·llrine has been passed. The bladder 
is found to be praotioally empty, albumen, erythro-
cytes with various amounts ot alteration, diminished 
urea and ohlorides, and granular oast in the sediment 
are found. An interval or improvement may appear, 
lasting tor two to six days with or without jaundioe 
and always with oontinued oliguria or anuria. Then 
any variety or evolution may be observed: oomplete 
anuria to the end reaohing a ureaio-like oondition 
and death in 8 to 12 days; or en the third to tourth 
day poor ooncentration or i.lrine followed by oliguria 
oranuria; or a permanently poor oonoentration diuresis; 
or else a better oonoentration with less water elimi-
nated. The general condition with regard to the under-
lying disease tor whioh the blood trans:rusion was given 
is usually undisturbed in its oourse. Pains are absent, 
pulse andtension usually unohanged. Conseoutive blood 
examination shows a steady increase in ozotamia and 
non protein introgen and a decrease in alkali reserve 
and oarbon dioxide oombining power with slight vari-
ation in the chlorides. The blood pressure may or 
may not be inoreased. The kidney funotion tests are 
reduced. Edema is always present. The oondition 
resembles experimental uranium. nitrate poisoning 
or biohloride or meroury poisoning. The entire phase 
lasts about ten days (16, 143). 
Third: The hydrio orisis phase is often skipped~ 
In this phase large amounts or water are eliminated, 
1800 oc within 24 hours. The urine is poor in urea 
and chlorides, ozotemia, increased non protein intro-
gen, decreased alkali reserve and oarbondioxide of 
the blood are found. The kidney function tests are 
redu.oed. There is always edema. The amount ot urea 
in the urine and the amount of urine excreted are 
.better prognostic stgns than the amount of hemoglobin 
excreted. The toxemia lags behind the elimination. 
Fourth: The last or terminal period is 8 to 12 
days or even 15 to 25 days after the transfusion was 
given. 1.rhere may be two possibilities, either favor-
able or unfavorable with all the range between. The 
favorable oases after a few days of crisis have normal 
diuresis with ohloruria and ozoturia and the p~tient 
begins oonvalesoenoe. Permanent sequelae have never 
been observed. In the unfavorable oases power ot kidney 
concentration rem.ains very low and death results in coma 
with uremia manifestations. (16, 143). 
The symptoms of unfavorable oases: 
The unfavorable oases result from inoompatible 
transfusion, and there is always the precocious aggra-
vation. Dige.stive disturbances are always present, 
beginning with a loss of appetite and then vomiting 
and diarrhea appear and eventually urea and ohlorides 
appear in both the vomitus and stools. There are 
pulmonary symptoms of Oheyne-Stokes syndrome, whiah 
may be related to the acidotio condition; nervou• 
symptoms or a progressive torpor from fatigue to 
somnolenoe and ooma interrupted by spasmodie move-
ments or oonvulsions. Death ll.su.ally resu.lts two 
to three days after ooma appears. The enttre time 
of the nephritis is usually about ten days and very 
rarely 25 days (16, 143). 
Other assooiated olinioal symptoms: 
Other assooiated clinical symptoms of post 
transfusion nephritides are: eruptions, peteohial 
or urticarial, jaundioe, edema, mild hematllrias with 
albumenuria, oylindric granules, increase of n~ea and 
slight deorease of alkali reserve, and with erythema, 
urtioaria, fungaoious edema and artioular pains. There 
are the benign or reflex nephritides, some lumbar pain, 
anllria of a varying d...iration, then diuresis and dis-
appearance of the disturbanoe without sequelae (143). 
Strange, but there seems to be no simple relation-
ship between the amount of blood injected and the 
severity ot the reaction nephritis {143). 
Explanation of Post transfusion nephritides: 
The explanation of post transfusion nephritides 
is that the blood is hemolyzed in vivo from inoom-
patibili ty; or from heating the blood too muoh, slightly 
above body temperature; or .from blood peouliarities; 
or the oondition may be due to metabolio disturbances. 
The hemoglobin from the destroyed red blood oells 
is exoreted by the kidneys with one ot the following 
possibilities ooourring: (a) It the reaotion ot 
the urine is above pH 6.0 the hemoglobin will be 
exoreted as oxyhemoglobin with no ill effects re-
sulting. (b} But it the reaction ot the urine is 
below pH 6.0 and there be s·iltf'ioient oonoentration 
of Na Cl (about 1%), brown pigment will be precipitat-
ed in the kidney tubules (5). 
It is reasoned that the hemoglobin passes through 
Bowman's capsule in the dil·\.lte transudate at about 
the pH ot the blood. In the tubules reabsorption 
concentrates and increases the aoidity ot the urine. 
The hemoglobin is precipitated, probably aa hematin. 
The tubules are ocoluded and renal tunotion is im-
paired (5). 
The mechanism or explanation by which incom-
patible blood damages the kidneys has four possibili-
ties aooording to Bordley (16). 1. The meohanioal 
blookage ot the tubules renders the kidney :f'unotion-
less as an excretory organ. 2. There are or may be 
certain bodies in the injected blood to which the 
kidneys are sensitive, and tunotional decline results 
trom a looal reaotion of the nature.or anaphylaotio 
shook. 3. "The immediate trans:f'~sion reaotion 
brings about a metabolic disturbanoe that atteota 
the renal tunotion. 4. By the action or toxio 
substances set tree in the blood at the time ot 
transfusion, the functioning renal tissue is so 
severely damaged that it is unable to perform its 
tunotions" (16}. 
Renal pathology and autopsy findings: 
-The renal pathology seems to be the obstruction 
of the tubular lwaens with masses of pigment derived 
from the hemoglobin (4la, 105). The autopsy findings 
ot the kidneys are: "edema and cellular infiltration 
of the interstitial tissue, dilatation or the inter-
oapular spaces of the glomeruli, dilitation ot the 
convoluted tubules, advanoed necrotic changes in the 
tubular epitheliwn, espeoially of the collecting 
tubules; with deposits or pigmented droplets in many 
of the cells and finally, the appearance in the 
tubular hemina of leuoocytes, large phagocytio wand-
ering cells, desquam.ated epithelium and peculiar 
pigments globules or various sizes" (16). This pig-
ment· is s1.1ggesti ve ot hemoglobin, and exoept tor it 
the kidneys are much like the kidneys following death 
trom merourio chloride poisoning. There is central 
necrosis of the liver. Findings in the other organs 
vary (16, 4la, 105). 
Experimentation and treatment: 
Experimentation study on dogs tollowing the 
intravenous injection or dog hemoglobin showed that 
if the urine was alkaline, the injection was without 
harmful effects; bat when the urine was acid, renal 
insuffioiency resulted, there was inoreased urea 
nitrogen (120 to 362.6 mg percent) and oreatinine 
(4.5 to 15 mg percent), coma and death in 4 to 10 
days resulted. The experiementation indicates the 
line of treatment in hemoglobinur~a whether it be 
d~e to transfusions, paroxysmal hemoglobin~ria, or 
blaokwater fever. Any type of therapy tending to 
• 
reduce the preoipetative taotors - that is acidity 
and sodinnohloride oonoentnation - sho~ld prove of 
value. The alkaline diuretics are transfusion ot 
.aocli\.Ull, bioarbona te as soon as possible should tend 
to minimize the precipitation in the tubules (5, 4la.). 
The treatment is prophylaxis by proper blood 
grouping bef'ore the transtusion is given ensuring 
compatibility; not over working the blood; and close 
observation or the patient during the injection, 
especially early; the injection being given sl~w; and 
discontinuing it if there are any signs of reaction. 
The treatment consists of adrenaline 5 to 10 minums 
(0.3 to 0.6 oo}, atropine 1/600 to 1/150 grains, 
with morphine 1/8 to 1/4 grains (121, 125) and 
intravenous solution or sodium bicarbonate 
10.7:1000 given right away. A oompatible blood 
transfusion is very helptul (143). If vomiting 
and diarrhea are present injections or normal 
saline with gluoose should be used. The rest ot 
the treatment is as in any acute nephritis (104, 
121, 125, 143}. In extreme oases radical experi-
mental procedures have been tried as kidney de-
oapsulation or de-inervation by the injeotion of the 
proper dorsal nerve roots or by high spinal anesthesia. 
Immediate transfusion ot compatible blood has been 
reoommended (143). 
THE USE OF CITRATE BLOOD 
In the oontroversy of the whole or the un-
modified method or blood transfusion versus the 
citrated or the modified method or blood trans-
f..ision oonsideration has been given: The oi tra te 
itself; the efteot ot oaloium immobilization; dist-
urbanoes in the hydrogen in oonoentration of the 
blood; injury of platelets; ohanges in fragility 
of the red blood oells; alterations in the hemo-
statio powers of the blood; immobilization of the 
white oells; ohanges in the opsonio index; the 
development of the antioomplimentary properties of 
the ser11m; alterations in the immunologio reaotions 
ot the serum in respect to antitoxio, virnoidal, 
baoterioidal, and other antibody properties (43, 58, 
~5, 144, 145). 
The oitrate reaotion: 
Citrate itself oan hardly seem a oause for post 
transfusion reaotions. But "oitrate reactions" has 
been mentioned by many writers as being oaused by the 
oitrate {17, 79). It is "oharaoterized by an unex-
plained slightly delayed febrile response; it is a 
common enough reaotion even when the blood is given 
witho~t the oitrate, and it fortunately seems harm-
!!fl""'... 
less." (16 & 67} Lewisohn (85, 86) thinks that 
the reactions with citrated and unoitrated blood 
are about equal in :rrequency o:r occurrence. He 
blames the mild post transtusion reactions upon un-
clean and contaminated apparatus (84). Sodium oitrate 
is rapidly oxidized and disappears quiokly trom the 
circulation when given intravenously (54, 122). 
Hemorrhage does not etteot this disappearance ot the 
sodium citrate. Repeated doses disappear more alowly. 
Citrate given orally causes alkaline urine but there 
is only a small amount ot the citrate in the urine. 
Intravenously 70 milligrams per kilogram of body 
weight, ma.king over about tive grams in the average 
adult, have given SJDlptoms. The f'atal dose is between 
0.4 and 1.6 grams per kilogram of body weight, making 
the :ratal dose abou.t 70 grams in the adult. The toxi-
oi ty ot it depends upon the rapidity ot injection, 
the taster it is injected the more toxic it becomes 
(122). In the average transiusion ot 500 coot blood, 
1.25 grams ot sodium citrate would be given. This is 
one-tourth the maximum sate dose (54, lOla). 
Calcium immobilization: 
"Some experimental work on citrate toxicity sug-
gest that when the calcium content of the blood has 
been depleted as it otten is in patients needing blood 
• 
transtllsion, a smaller doee than five grams may be 
toxic. Possibly therein lies the reason that the· 
citrate method gives more reactions than noted with 
the whole blood method." (lOla) It the recipients 
are thought or ~ound to be low in blood calcium, they 
oan be given oaloiwn gluconate intravenously, and the 
condition taken care ot. 
Sodium oitrate effects have been studied both 
in experimental animals and in the various blood tests, 
and its injurious etfeots upon the platelets, red 
blood oells, opsonio index, antioomplimentary pro-
perties of serum and lowered phaoooytio properties 
refuted (og, 122). There is no increase in the 
fragility of the white or red oells (84, 95). B·11t 
there may be some ef'feot upon pH and oalloidal equili-
briill11 whioh is theoreticalas yet (95). The hemostatic 
power or citrated blood as compared to uncitrated blood 
in p11rp11ra hemorrhagica, hemophilia, and hemorrhagic 
disease of the new born oannot be definitely stated; 
but intravenous citrate solutions have been said to 
shorten the clotting time in hemorrhage exoept when 
due to platelet disturbanoe (99, 117). But according 
to Lewisohn (85, 86) and Jenings (73) citrate blood 
has been proved to be harmless and may be used in any 
disease where transfusion is indioated• 
Ef'teots ot oi trate upon immunotranst·usion: 
In the preparation ot oonvalsoent sera the 
preservatives used do not atteot the potenoy ot 
the immune bodies (eg ammonium. sulfate, trioresol}. 
And as tar as o~r present knowledge, oitrate would 
have no d·e11 teJ;"ious efteot upon immune bloods (92, 
102• 159, 160). However, Colebrook and Storer (32} 
showed that "the addition of deoaloitying agents 
to normal blood considerably reduces its power to 
kill staphylooooous and streptooooous in some way 
intertering with the tunotion of the leuooaytes. 
But citrate did not affect the pneumoooooidal power 
ot blood (2?). However, it was found that the 
oomplement content or unoitrated blood was increased 
over that of oitrated blood and hence the baotori-
oidal power of the blood which is very olosely re-
lated (109, 111). Okomoto (101) oonoludes that un-
oitrated blood has no advantages over citrated blood 
in transfusion ot rabbits upon normal and immune 
agglutinins and normal and immune hemolysis. 
Comparison of citrate blood with unoitrated blood: 
It would seem that with a very sick patient 
"skill on the part or the operator and minimal dis-
turbanoe to the patient are matters or tar greater 
importance than the supposed merits ot anyone method 
over those or another." (111) The citrate method~ 
minimizes the disturbanoe to the patient; veins 
need not be exposed; the blood may be given slowly; 
the skill is easily developed; and the equipment 
is simple, easy to handle and olean, and the donor 
is not directly exposed to the reoipient. In 
inteotious diseases and blood dysooasias, the advan-
tage may be with unoitrated blood, it would seem; 
but the evidence is inoomplete (109, 111). 
In any transf'usion the delicate blood tissue 1• 
traumatized, perhaps as muoh in the rush method as in 
the anticoagulant method (109, 111). 
Advantages of' the citrate method: 
The advantages of the citrate method are: First, 
its simplicity; seoond, speed is not necessary and 
so the blood oan be given slowly enough to anticipate 
severe reaction and to minimize speed shook. It is 
true that slight febrile reaotions {l to 2 degrees F) 
ooour more frequently following injeotion of citrated 
blood than ot unoitrated blood, but these are ot no 
serious moment. Third, the coagulation time is not 
prolonged as has been thought, but it is actually 
shortened. Therefore, there are no diseases in whioh 
the use ot citrated blood is oontra.tndioated. 
The citrate method would seem the method o~ 
choice tor the average practitioner who has only an 
oooasional transfusion to perform. For the expert 
who does many transfusions, one of the direct 
methods may be desirable (54). 
Dangers of unmodified blood: 
The dangers ot unmodified blood are: First, 
the possibility of a olo• forming in the apparatus 
and interrupting the procedure. this is avoided 
by the utmost speed and preoision. Seoond, one 
cannot then inject a small amount ot blood slowly 
to see whether a severe reaction is imminent. Third, 
the donor must be at the bedside of the reoipient, 
this is objectionable to nervous or oritioally ill 
patients. Fourth, blood is increasingly toxio as 
the ohemioal ohanges preceding ooag11lation take 
place; so it the blood in the apparatus is on the 
verge of clotting, one is actually administering a 
toxic substance (54). 
ACCIDENTAL TRANSMISSION OF DISEASES 
BY BLOOD TRANSFUSION 
There have undoubtedly been many more diseases 
aooidently transmitted than have been reported. In 
a survey made by Hendrick (29) in 1935, he reported, 
"thirty-five oases of syphilis, thirty of malaria, 
three of measles, two of smallpox, one or typhus 
fever, three of' allergy, and three of tuberoulosis." 
transmitted by transfusion. There was a death two 
weeks :f'ollowing an aooidental transfusion from a donor 
with aoate myeloid leukemia (29). 
Byphilis transmission: 
The first aooidental transmission of syphilis 
oy transfusion was reported in 1915 (112a). There 
has been a total of 68 oases reported. (112a). One 
oase in whioh two generations were given it direotly 
by transfusion or an expectant mother. Both the 
mother and the unborn baby got syphilis. 
The way suoh mistakes oan be eliminated is for 
the physioian to never do a blood transfusion without 
the written report of the laboratory regarding the 
prospective donor's serology. A verbal report sho~ld 
not be taken. A Kahn test oan be performed in two 
hours. If the emergenoy cannot wait that long and 
there are no available tested and serologioal donors 
obtainable, the folks of the expected re~ipient after 
having the situation explained may be asked to sign 
a written release, releasing the dootor if the patient 
should get syphilis following suoh an emergency blood 
transfusion. S\lch a transmitted syphilis has no 
oanohre, but in about two and one halt months the 
seoondary rash may appear as in any oase of syphilis 
and the other clinical symptoms usually resemble 
those of syphilis gotten in the usual manner (75). 
Any one who has ever had syphilis should not be 
a donor tor blood transtusion, although many physioians 
think there is no danger ot using inactive oases for 
donors, except when it is a life saving procedure, 
and then having the patient or other responsible person 
sign a permit releasing the dootor in case the patient 
gets syphilis. The dootor may in the absence of a 
responsible person and with a patient that cannot give 
a rational consent, take this responsibility upon 
himself and be within his legal right of' exercising 
a "reasonable care". It may be the means of saving 
the patients life in an exoeptional case (?5, 7g). 
Malaria transmission: 
Malaria has been transmitted aocidently by trans-
fusion to both donor and reeipient. ot oourse, trans-
mission to reo1p1ent is more common, and has been done 
even when the donor did not know he had malaria, or 
when he had not had an attack for forty years (24). 
There have been reported f ou.r oases ot malaria from 
one donor within two months and a.bou.t thirty oases 
in all (29). The incubation period varies trom one 
to titty-six days with an average from one and one 
half to three weeks. Less than halt ot the donors 
had demonstrable malarial parasites in their blood 
smears, and less than half of them ever had symptoms 
of malaria. Protection can only be had by exoluding 
all inhabitant of malarial regions from being donors 
(154). 
Passive transfer of allergy: 
Ramirez ~ tells of a recipient several weeks 
following transfusion from a donor sensitive to horse 
dander, who was then himself sensitive to horses. 
Hendriok (29) tells or theee transmissions of allergy 
aeoidentally by transfusion. Therefore, donors should 
always be questioned regarding allergy and asthma. 
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